Maximus Inc. reported full year revenue of $5.4 billion for fiscal year 2025, a 2.4% increase from the prior year, with organic growth of 3.9% mainly driven by higher demand for clinical services in the U.S. Federal Services Segment. The company achieved an operating margin of 9.7% and an adjusted EBITDA margin of 12.9%. Diluted earnings per share were $5.51, and adjusted diluted earnings per share were $7.36. Cash flows from operating activities totaled $429 million, and free cash flow was $366 million. Maximus repurchased 5.8 million shares for $457 million during the year. The leverage ratio at the end of the period was 1.5x. For fiscal year 2026, the company expects free cash flow between $450 million and $500 million and plans to focus on expansion in U.S. Federal markets and AI-enabled automation. A quarterly cash dividend of $0.30 per share is payable on December 1, 2025.